SCHEMBL17420274

SCHEMBL17420274

O=C(O)c1ccc2ccc(N3CCC4(CCOCC4)CC3)cc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM2 Q9P1W9 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ SLC16A3 O15427 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP3A4 P08684 5/20 0.40
▸ CYP2C8 P10632 3/20 0.40
▸ NR1H4 Q96RI1 3/20 0.40
▸ USP2 O75604 3/20 0.39
▸ KMO O15229 1/20 0.39
▸ MGAM O43451 1/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17420313 0.87 SLC16A3 (0.52) ALDH1A1MEN1KMT2AKDM4EPOLB
SCHEMBL17420285 0.80 TERT (0.60) PIM2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL17420335 0.80 TERT (0.56) PIM2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL17420298 0.79 PIM2 (0.53) PIM2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL17420314 0.77 KDM4E (0.52) PIM2ALDH1A1MEN1KMT2AKDM4E
SCHEMBL9837631 0.77 HTR3E (0.49) ALDH1A1KDM4ETSHRCYP3A4USP2
SCHEMBL17420283 0.74 PIM2 (0.48) PIM2ALDH1A1KDM4EPOLBTDP1
SCHEMBL24532544 0.73 MEN1 (0.47) ALDH1A1MEN1KMT2AKDM4EPOLB
SCHEMBL17420281 0.72 PIM2 (0.51) PIM2ALDH1A1KDM4ETSHRCYP3A4
SCHEMBL17420317 0.72 HRH3 (0.43) PIM2TSHRUSP2MGAMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890162-B2 Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2018-02-13 — — US disclosed
US-9890162-B2 Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2018-02-13 — — US disclosed
US-9890162-B2 Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2018-02-13 — — US disclosed
US-20170253587-A1 BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2017-09-07 — — US disclosed
US-20170253587-A1 BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2017-09-07 — — US disclosed
US-20170253587-A1 BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2017-09-07 — — US disclosed
US-9580418-B2 Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2017-02-28 — — US disclosed
US-9580418-B2 Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2017-02-28 — — US disclosed
US-9580418-B2 Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2017-02-28 — — US disclosed
US-20160009714-A1 BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2016-01-14 — — US disclosed
US-20160009714-A1 BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2016-01-14 — — US disclosed
US-20160009714-A1 BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE CORPORATION 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009714-A1 BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM1, PIM2, PIM3 PIM2 2/4885ALDH1A1 2531/4885MEN1 4226/4885
US-20170253587-A1 BICYCLIC AROMATIC CARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM1, PIM2, PIM3 PIM2 2/4885ALDH1A1 2531/4885MEN1 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback